Cited by 85Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder ResearchFunctional Brain Connectivity Studies

Classification Accuracy of Neuroimaging Biomarkers in Attention-Deficit/Hyperactivity Disorder: Effects of Sample Size and Circular Analysis

Open access
Pulini, Alfredo A., Kerr, Wesley T., Loo, Sandra K., Lenartowicz, Agatha·2019·Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Abstract

Background Motivated by an inconsistency between reports of high diagnosis-classification accuracies and known heterogeneity in attention-deficit/hyperactivity disorder (ADHD), this study assessed classification accuracy in studies of ADHD as a function of methodological factors that can bias results. We hypothesized that high classification results in ADHD diagnosis are inflated by methodological factors.Methods We reviewed 69 studies (of 95 studies identified) that used neuroimaging features to predict ADHD diagnosis. Based on reported methods, we assessed the prevalence of circular analysis, which inflates classification accuracy, and evaluated the relationship between sample size and accuracy to test if small-sample models tend to report higher classification accuracy, also an indicator of bias.Results Circular analysis was detected in 15.9% of ADHD classification studies, lack of independent test set was noted in 13%, and insufficient methodological detail to establish its presence was noted in another 11.6%. Accuracy of classification ranged from 60% to 80% in the 59.4% of reviewed studies that met criteria for independence of feature selection, model construction, and test datasets. Moreover, there was a negative relationship between accuracy and sample size, implying additional bias contributing to reported accuracies at lower sample sizes.Conclusions High classification accuracies in neuroimaging studies of ADHD appear to be inflated by circular analysis and small sample size. Accuracies on independent datasets were consistent with known heterogeneity of the disorder. Steps to resolve these issues, and a shift toward accounting for sample heterogeneity and prediction of future outcomes, will be crucial in future classification studies in ADHD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bpsc.2018.06.003

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Given the complexity and heterogeneity of neurodevelopmental disorders in terms of pathophysiology, it is highly unlikely that biomarker applications based on a single parameter will be meaningful in clinical practice.

    “Arguably, given the complexity and heterogeneity of neurodevelopmental disorders in terms of pathophysiology, it is highly unlikely that biomarker applications based on a single parameter will be meaningful in clinical practice 44-47 .”

    From Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review (2023) · cites this paper as [46]

    The Discussion ('Value of biomarkers in ADHD diagnosis and beyond'; page unavailable) links ADHD heterogeneity to variable classification accuracy and says the biomarkers studied are not accurate enough to use without other supporting information in clinical practice. The Conclusions likewise call them too inaccurate to be independently useful for ADHD diagnosis. The claim extends this ADHD-specific finding to neurodevelopmental disorders generally and suggests single-parameter biomarkers are unlikely to be clinically meaningful at all, whereas the paper says the biomarkers may have value as adjuncts. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 119 · Cited by 85

Research works printed but not linked: 4

  1. [15]Fu J, Liu Z, Gao X (2013): Investigtion of low frequency drift in attention deficit hyperactivity disorder fMRI signal. Third International Conference on Information Science and Technology. Yangzhou, Jiangsu, China: IEEE.
  2. [79]Allahverdi A, Nasrabadi AM, Mohammad M (2011): Detecting ADHD children using symbolic dynamic of nonlinear features of EEG 19th Iranian Confernece on Electrical Engineering. Tehran, Iran: IEEE.
  3. [90]Snyder SM, Quintana H, Sexson SB, Knott P, Haque AFM, Reynolds DA (2008): Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiat Res. 159: 346– 358. 18423617
  4. [91]Ghiassian S, Greiner R, Jin P, Brown MRG (2013): Learning to Classify Psychiatric Disorders based on fMR Images: Autism vs Healthy and ADHD vs Healthy Proceedings of the NIPS 2013 Workshop on Machine Learning and Interpretation in Neuroimaging. Lake Tahoe.

Authors
Pulini, A. A., Kerr, W. T., Loo, S. K., & Lenartowicz, A.
Affiliations
  • Université Paris Descartes (FR)
  • Eisenhower Medical Center (US)
  • University of California, Los Angeles (US)
Corresponding author
Lenartowicz, Agatha
Venue
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Publisher
Elsevier BV
Published
2019-02
Volume
4
Issue
2
Pages
108-120
ISSN
2451-9022 (ISSN-L)
OpenAlex
W2810339787
Cited by
85
References
119
Citations by year
2026: 4 · 2025: 10 · 2024: 14 · 2023: 14 · 2022: 14 · 2021: 12 · 2020: 9 · 2019: 7 · 2018: 1
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry Cognitive Neuroscience and Neuroimaging (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institutes of Health (MH101282, NS97484)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
attention deficit hyperactivity disorder, neuroimaging biomarkers, classification accuracy, sample size, methodological bias, sample heterogeneity, diagnostic prediction
MeSH terms
Machine Learning, Attention Deficit Disorder with Hyperactivity, Brain, Humans, Reproducibility of Results, Biomarkers, Sample Size, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review